Cutaneous mucormycosis in advanced HIV disease

dc.creatorMoreira, José
dc.creatorRidolfi, Felipe
dc.creatorAlmeida-Paes, Rodrigo
dc.creatorVaron, Andrea
dc.creatorLamas, Cristiane C.
dc.date2019-02-22T11:57:33Z
dc.date2019-02-22T11:57:33Z
dc.date2016
dc.date.accessioned2023-09-26T22:52:45Z
dc.date.available2023-09-26T22:52:45Z
dc.identifierMOREIRA, José et al. Cutaneous mucormycosis in advanced HIV disease. Brazilian Journal of Infectious Diseases, v. 20, n. 6, p. 637-640, 2016.
dc.identifier1413-8670
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/31839
dc.identifier10.1016/j.bjid.2016.06.004
dc.identifier1678-4391
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8884286
dc.descriptionAngionvasive mucormycosis is an emerging fungal disease known to affect mainly diabetics or subjects with profound neutropenia. Infection usually occurs through the inhalation route, but cutaneous inoculation may occur after trauma or burns. However, mucormycosis remains unusual in HIV infection. We report a fatal case of cutaneous mucormycosis due to Rhizopus arrhizus involving the scalp following herpes zoster infection. The patient was a 42-year-old man with advanced AIDS failing on salvage antiretroviral therapy. The fungus was diagnosed on the basis of histopathology and culture. Our case emphasizes the need to consider mucormycosis in the differential diagnosis of necrotic cutaneous lesions in patients with late-stage HIV disease.
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsopen access
dc.subjectHIV
dc.subjectMucormycosis
dc.subjectRhizopus
dc.subjectAIDS
dc.titleCutaneous mucormycosis in advanced HIV disease
dc.typeArticle


Este ítem pertenece a la siguiente institución